Integra Lifesciences (IART)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2010 | 12-2009 | 09-2009 | 06-2009 | 03-2009 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 81,674 | 71,891 | 106,747 | 138,717 | 185,630 |
| Receivables | 98,532 | 103,228 | 101,379 | 101,462 | 101,610 |
| Inventories | 142,113 | 140,240 | 140,541 | 139,319 | 141,582 |
| Income taxes - deferred | 29,444 | 29,972 | 20,939 | 21,115 | 21,325 |
| TOTAL | $372,844 | $365,363 | $395,795 | $423,249 | $477,567 |
| Non-Current Assets | |||||
| PPE Net | 83,418 | 83,526 | 70,834 | 70,777 | 69,783 |
| Intangibles | 464,133 | 473,058 | 479,037 | 429,214 | 427,930 |
| Other Non-Current Assets | 17,602 | 18,155 | 27,570 | 23,132 | 20,137 |
| TOTAL | $565,153 | $574,739 | $577,441 | $523,123 | $517,850 |
| Total Assets | $937,997 | $940,102 | $973,236 | $946,372 | $995,417 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 77,470 | 76,760 | 94,233 | 110,443 | N/A |
| Accounts payable and accrued liabilities | 25,403 | 24,598 | 20,345 | 19,899 | 22,834 |
| Accrued Expenses | 52,370 | 51,295 | 96,659 | 43,167 | 44,664 |
| TOTAL | $159,180 | $156,730 | $215,320 | $216,834 | $170,671 |
| Non-Current Liabilities | |||||
| Long Term Debt | 145,000 | 160,000 | 160,000 | 160,000 | 160,000 |
| Deferred Revenues | 3,937 | 4,077 | 4,083 | 3,325 | 3,173 |
| Other Non-Current Liabilities | 167,445 | 169,168 | 167,494 | 166,763 | 290,477 |
| TOTAL | $320,897 | $338,487 | $327,494 | $326,763 | $450,477 |
| Total Liabilities | $480,077 | $495,217 | $542,814 | $543,597 | $621,148 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 58,005 | 57,358 | 56,962 | 56,875 | 56,804 |
| Common Shares | 353 | 350 | 348 | 347 | 345 |
| Retained earnings | 182,383 | 167,161 | 151,430 | 136,998 | 125,773 |
| Other shareholders' equity | -2,664 | 8,525 | 18,259 | 10,548 | -2,979 |
| TOTAL | $457,920 | $444,885 | $430,422 | $402,775 | $374,269 |
| Total Liabilities And Equity | $937,997 | $940,102 | $973,236 | $946,372 | $995,417 |